Endometrial Ablation With Non-hysteroscopic Methods

Aristotle University Of Thessaloniki66 enrolled

Overview

Endometrial ablation in women with dysfunctional uterine bleeding using second generation ablation devices is a common widespread therapeutic approach. This study aims to prove that amenorrhoea rates using Novasure are higher than those observed in microwave endometrial ablation, one year following intervention.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

NONE

Enrollment

Conditions

Dysfunctional Uterine Bleeding

Interventions

MEADEVICE

Microwave endometrial ablation device

NovasureDEVICE

Bipolar impedence control system

Eligibility

Sex: FEMALEMin age: 30 YearsMax age: 49 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Women presenting with dysfunctional uterine bleeding having completed their family planning(no wish for further childbearing) Exclusion Criteria: * Endometrial pathology * FSH \> 20 day 2 -day 3 of the cycle * Clotting Disorders * Thyroid Dysfunction

Locations (2)

First Dept. Of ObGyn, Medical School Aristotle University of Thessaloniki, Papageorgiou Hospital

Thessaloniki, Thessaloniki, Greece

First Dept. of ObGyn, Medical School, Aristotle University of Thessaloniki, Papageorgiou Hospital

Thessaloniki, Thessaloniki, Greece

Outcomes

Primary Outcomes

Amenorrhoea rates one year after intervention

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.